Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). (Q47901523)

6 February 2018

title

Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). (English)

1 reference

6 February 2018

inflammatory bowel diseases

main subject

0 references

author name string

S Dionne

1

1 reference

6 February 2018

I D D'Agata

2

1 reference

6 February 2018

J Hiscott

3

1 reference

6 February 2018

T Vanounou

4

1 reference

6 February 2018

E G Seidman

5

1 reference

6 February 2018

publication date

1 June 1998

1 reference

6 February 2018

Clinical and Experimental Immunology

published in

1 reference

6 February 2018

volume

112

1 reference

6 February 2018

issue

3

1 reference

6 February 2018

page(s)

435-442

1 reference

6 February 2018

Cytokines in inflammatory bowel disease

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Immunogenetics of cytokines. Relevance for future research on inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Mucosal interleukin-6 secretion in ulcerative colitis. Effects of anti-inflammatory drugs and T-cell stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14 L1 monocyte derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2249.1998.00595.X

Quantitative PCR analysis of TNF-alpha and IL-1 beta mRNA levels in pediatric IBD mucosal biopsies

21 January 2018

1 reference

12 December 2020

Tumor necrosis factor-alpha inhibits lipid and lipoprotein transport by Caco-2 cells.

1 reference

12 December 2020

Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin

1 reference

12 December 2020

Biologic basis for interleukin-1 in disease

1 reference

12 December 2020

Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF).

1 reference

12 December 2020

Identification of soluble interleukin-1 binding protein in cell-free supernatants. Evidence for soluble interleukin-1 receptor

1 reference

12 December 2020

Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease

1 reference

12 December 2020

Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-gamma mRNA, and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spl

1 reference

12 December 2020

Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis

1 reference

12 December 2020

The role of the mucosal immune system in inflammatory bowel disease

1 reference

12 December 2020

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

12 December 2020

Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis

1 reference

12 December 2020

T-cell activation can induce either mucosal destruction or adaptation in cultured human fetal small intestine

1 reference

12 December 2020

Pathogenesis of ulcerative colitis

1 reference

12 December 2020

Differential regulation of cytokine production in lipopolysaccharide tolerance in mice

1 reference

12 December 2020

Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist

1 reference

12 December 2020

Interleukin-10 production during septicaemia

1 reference

12 December 2020

Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats.

1 reference

12 December 2020

Comparative production of IL-1 beta and IL-1 alpha by LPS-stimulated human monocytes: ELISAs measurement revisited

1 reference

12 December 2020

Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.

1 reference

12 December 2020

Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism

1 reference

12 December 2020

Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation

1 reference

12 December 2020

Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease

1 reference

12 December 2020

Interleukin-1, tumor necrosis factor and their specific inhibitors.

1 reference

12 December 2020

Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease

1 reference

12 December 2020

Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

1 reference

12 December 2020

Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease

1 reference

12 December 2020

10.1046/J.1365-2249.1998.00595.X

Identifiers

DOI

1 reference

6 February 2018

PMC publication ID

1904987

0 references

1 reference

6 February 2018